ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för irinotecan hydrochloride hydrate. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

14 träffar

Bibliografisk träff 2016-02-01

Long-term survival in small-cell carcinoma of the endometrium with liver and brain metastases.

Sawada M, Matsuzaki S, Yoshino K, Ueda Y, Yoshida S, Kimura T, Ogita K.

Anticancer Drugs · journal article; case reports · DOI 10.1097/cad.0000000000000289

Bibliografisk träff 2016-02-01

Chemotherapeutic agent CPT-11 eliminates peritoneal resident macrophages by inducing apoptosis.

Huang MY, Pan H, Liang YD, Wei HX, Xu LH, Zha QB, He XH, Ouyang DY.

Apoptosis · research support, non-u.s. gov't; journal article · DOI 10.1007/s10495-015-1193-2

Bibliografisk träff 2016-01-27

Biophysical and molecular docking insight into interaction mechanism and thermal stability of human serum albumin isoforms with a semi-synthetic water-soluble camptothecin analog irinotecan hydrochloride.

Ishtikhar M, Khan MV, Khan S, Chaturvedi SK, Badr G, Mahmoud MH, Khan RH.

J Biomol Struct Dyn · journal article · DOI 10.1080/07391102.2015.1082504

Bibliografisk träff 2015-12-17

Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expression.

Fang ZZ, Zhang D, Cao YF, Xie C, Lu D, Sun DX, Tanaka N, Jiang C, Chen Q, Chen Y, Wang H, Gonzalez FJ.

Toxicol Appl Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1016/j.taap.2015.12.003

Bibliografisk träff 2015-12-04

Langmuir monolayers and Differential Scanning Calorimetry for the study of the interactions between camptothecin drugs and biomembrane models.

Casadó A, Giuffrida MC, Sagristá ML, Castelli F, Pujol M, Alsina MA, Mora M.

Biochim Biophys Acta · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbamem.2015.12.007

Bibliografisk träff 2015-11-05

Development and characterization of pH responsive polymeric nanoparticles of SN-38 for colon cancer.

Prasad S, Dangi JS.

Artif Cells Nanomed Biotechnol · journal article · DOI 10.3109/21691401.2015.1105239

Bibliografisk träff 2015-11-02

Organic Anion Transporting Polypeptide (OATP)2B1 Contributes to Gastrointestinal Toxicity of Anticancer Drug SN-38, Active Metabolite of Irinotecan Hydrochloride.

Fujita D, Saito Y, Nakanishi T, Tamai I.

Drug Metab Dispos · research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.115.066712

Bibliografisk träff 2015-03-01

Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, with irinotecan hydrochloride on human colorectal and gastric cancer xenografts.

Nukatsuka M, Nakagawa F, Saito H, Sakata M, Uchida J, Takechi T.

Anticancer Res · journal article

Bibliografisk träff 2014-09-01

[Clinical efficacy of low-dose CDDP and CPT-11 therapy as second- or third-line chemotherapy for advanced and recurrent gastric cancer].

Ito S, Takagawa R, Minami Y, Watanabe J, Morita T, Mogaki M, Masui H.

Gan To Kagaku Ryoho · journal article

Bibliografisk träff 2014-07-01

[Pharmacokinetics of SN-38 in rats and tissue distribution of 7-ethyl-10-hydroxycamptothecin in mice after intravenous injection of irinotecan hydrochloride nanoparticles].

Yang FY, Zhang WP, Wang XY, Yang WC, Dang HW.

Yao Xue Xue Bao · journal article

Bibliografisk träff 2014-03-01

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study).

Shoji T, Takatori E, Kaido Y, Omi H, Yokoyama Y, Mizunuma H, Kaiho M, Otsuki T, Takano T, Yaegashi N, Nishiyama H, Fujimori K, Sugiyama T.

Cancer Chemother Pharmacol · research support, non-u.s. gov't; research-article; clinical trial, phase i; journal article · DOI 10.1007/s00280-014-2418-8

Bibliografisk träff 2014-01-15

IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.

Guabiraba R, Besnard AG, Menezes GB, Secher T, Jabir MS, Amaral SS, Braun H, Lima-Junior RC, Ribeiro RA, Cunha FQ, Teixeira MM, Beyaert R, Graham GJ, Liew FY.

Mucosal Immunol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/mi.2013.124

Bibliografisk träff 2013-11-04

P7 peptides targeting bFGF sensitize colorectal cancer cells to CPT-11.

Luo W, Yu Y, Wang R, He D, Wang C, Zeng X, Chen X, Tan X, Huang T, Wu X.

Int J Mol Med · research support, non-u.s. gov't; journal article · DOI 10.3892/ijmm.2013.1547

Bibliografisk träff 2013-06-01

[Pharmacokinetics and tissue distribution of irinotecan hydrochloride nanoparticles].

Yang FY, Zhang WP, Chen HL, Fu Y, Wang XY, Wei SJ, Yang XY, Zhang YX, Dang HW.

Yao Xue Xue Bao · journal article